Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 112

1.

Pretreatment cerebral metabolic activity correlates with antidepressant efficacy of vagus nerve stimulation in treatment-resistant major depression: a potential marker for response?

Conway CR, Chibnall JT, Gangwani S, Mintun MA, Price JL, Hershey T, Giuffra LA, Bucholz RD, Christensen JJ, Sheline YI.

J Affect Disord. 2012 Aug;139(3):283-90. doi: 10.1016/j.jad.2012.02.007. Epub 2012 Mar 5.

PMID:
22397889
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Association of cerebral metabolic activity changes with vagus nerve stimulation antidepressant response in treatment-resistant depression.

Conway CR, Chibnall JT, Gebara MA, Price JL, Snyder AZ, Mintun MA, Craig AD, Cornell ME, Perantie DC, Giuffra LA, Bucholz RD, Sheline YI.

Brain Stimul. 2013 Sep;6(5):788-97. doi: 10.1016/j.brs.2012.11.006. Epub 2013 Feb 13.

PMID:
23485649
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Brain blood-flow change with acute vagus nerve stimulation in treatment-refractory major depressive disorder.

Conway CR, Sheline YI, Chibnall JT, Bucholz RD, Price JL, Gangwani S, Mintun MA.

Brain Stimul. 2012 Apr;5(2):163-71. doi: 10.1016/j.brs.2011.03.001. Epub 2011 Apr 3.

PMID:
22037127
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Chronic vagus nerve stimulation for treatment-resistant depression increases regional cerebral blood flow in the dorsolateral prefrontal cortex.

Kosel M, Brockmann H, Frick C, Zobel A, Schlaepfer TE.

Psychiatry Res. 2011 Mar 31;191(3):153-9. doi: 10.1016/j.pscychresns.2010.11.004.

PMID:
21306877
[PubMed - indexed for MEDLINE]
5.

Baseline brain metabolism in resistant depression and response to transcranial magnetic stimulation.

Paillère Martinot ML, Martinot JL, Ringuenet D, Galinowski A, Gallarda T, Bellivier F, Lefaucheur JP, Lemaitre H, Artiges E.

Neuropsychopharmacology. 2011 Dec;36(13):2710-9. doi: 10.1038/npp.2011.161. Epub 2011 Aug 17.

PMID:
21849980
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Pretreatment regional brain glucose uptake in the midbrain on PET may predict remission from a major depressive episode after three months of treatment.

Milak MS, Parsey RV, Lee L, Oquendo MA, Olvet DM, Eipper F, Malone K, Mann JJ.

Psychiatry Res. 2009 Jul 15;173(1):63-70. doi: 10.1016/j.pscychresns.2008.09.004. Epub 2009 May 14.

PMID:
19446443
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Insulin resistance and Alzheimer-like reductions in regional cerebral glucose metabolism for cognitively normal adults with prediabetes or early type 2 diabetes.

Baker LD, Cross DJ, Minoshima S, Belongia D, Watson GS, Craft S.

Arch Neurol. 2011 Jan;68(1):51-7. doi: 10.1001/archneurol.2010.225. Epub 2010 Sep 13.

PMID:
20837822
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Sleep deprivation PET correlations of Hamilton symptom improvement ratings with changes in relative glucose metabolism in patients with depression.

Wu JC, Gillin JC, Buchsbaum MS, Schachat C, Darnall LA, Keator DB, Fallon JH, Bunney WE.

J Affect Disord. 2008 Apr;107(1-3):181-6. Epub 2007 Nov 26.

PMID:
18031825
[PubMed - indexed for MEDLINE]
9.

The effects of ECT on brain glucose: a pilot FDG PET study.

Henry ME, Schmidt ME, Matochik JA, Stoddard EP, Potter WZ.

J ECT. 2001 Mar;17(1):33-40.

PMID:
11281513
[PubMed - indexed for MEDLINE]
10.

Effectiveness and safety of vagus nerve stimulation for severe treatment-resistant major depression in clinical practice after FDA approval: outcomes at 1 year.

Cristancho P, Cristancho MA, Baltuch GH, Thase ME, O'Reardon JP.

J Clin Psychiatry. 2011 Oct;72(10):1376-82. doi: 10.4088/JCP.09m05888blu.

PMID:
21295002
[PubMed - indexed for MEDLINE]
11.

Cerebral glucose metabolism abnormalities in patients with major depressive symptoms in pre-dialytic chronic kidney disease: statistical parametric mapping analysis of F-18-FDG PET, a preliminary study.

Song SH, Kim IJ, Kim SJ, Kwak IS, Kim YK.

Psychiatry Clin Neurosci. 2008 Oct;62(5):554-61. doi: 10.1111/j.1440-1819.2008.01849.x.

PMID:
18950375
[PubMed - indexed for MEDLINE]
12.

Neuroanatomic correlates of psychopathologic components of major depressive disorder.

Milak MS, Parsey RV, Keilp J, Oquendo MA, Malone KM, Mann JJ.

Arch Gen Psychiatry. 2005 Apr;62(4):397-408.

PMID:
15809407
[PubMed - indexed for MEDLINE]
13.

A pilot study of vagus nerve stimulation (VNS) for treatment-resistant anxiety disorders.

George MS, Ward HE Jr, Ninan PT, Pollack M, Nahas Z, Anderson B, Kose S, Howland RH, Goodman WK, Ballenger JC.

Brain Stimul. 2008 Apr;1(2):112-21. doi: 10.1016/j.brs.2008.02.001. Epub 2008 Mar 28.

PMID:
20633378
[PubMed - indexed for MEDLINE]
14.

Decreased prefrontal, anterior cingulate, insula, and ventral striatal metabolism in medication-free depressed outpatients with bipolar disorder.

Brooks JO 3rd, Wang PW, Bonner JC, Rosen AC, Hoblyn JC, Hill SJ, Ketter TA.

J Psychiatr Res. 2009 Jan;43(3):181-8. doi: 10.1016/j.jpsychires.2008.04.015. Epub 2008 Jun 25.

PMID:
18582900
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Neural correlates of rapid antidepressant response to ketamine in treatment-resistant unipolar depression: a preliminary positron emission tomography study.

Carlson PJ, Diazgranados N, Nugent AC, Ibrahim L, Luckenbaugh DA, Brutsche N, Herscovitch P, Manji HK, Zarate CA Jr, Drevets WC.

Biol Psychiatry. 2013 Jun 15;73(12):1213-21. doi: 10.1016/j.biopsych.2013.02.008. Epub 2013 Mar 27.

PMID:
23540908
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Prefrontal cortical blood flow predicts response of depression to rTMS.

Weiduschat N, Dubin MJ.

J Affect Disord. 2013 Sep 5;150(2):699-702. doi: 10.1016/j.jad.2013.04.049. Epub 2013 May 22.

PMID:
23707032
[PubMed - indexed for MEDLINE]
17.

Differences in brain glucose metabolism between responders to CBT and venlafaxine in a 16-week randomized controlled trial.

Kennedy SH, Konarski JZ, Segal ZV, Lau MA, Bieling PJ, McIntyre RS, Mayberg HS.

Am J Psychiatry. 2007 May;164(5):778-88.

PMID:
17475737
[PubMed - indexed for MEDLINE]
18.

Regional cerebral glucose utilization in patients with a range of severities of unipolar depression.

Kimbrell TA, Ketter TA, George MS, Little JT, Benson BE, Willis MW, Herscovitch P, Post RM.

Biol Psychiatry. 2002 Feb 1;51(3):237-52.

PMID:
11839367
[PubMed - indexed for MEDLINE]
19.

Effect of magnetic seizure therapy on regional brain glucose metabolism in major depression.

Hoy KE, Thomson RH, Cherk M, Yap KS, Daskalakis ZJ, Fitzgerald PB.

Psychiatry Res. 2013 Feb 28;211(2):169-75. doi: 10.1016/j.pscychresns.2012.08.003. Epub 2012 Nov 11.

PMID:
23149039
[PubMed - indexed for MEDLINE]
20.

Positron emission tomography of regional brain metabolic responses to a serotonergic challenge in major depressive disorder with and without borderline personality disorder.

Oquendo MA, Krunic A, Parsey RV, Milak M, Malone KM, Anderson A, van Heertum RL, John Mann J.

Neuropsychopharmacology. 2005 Jun;30(6):1163-72.

PMID:
15770239
[PubMed - indexed for MEDLINE]
Free Article
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk